Valentina Ambrosini, Emilia Fortunati, Stefano Fanti, Stephan Ursprung, Luigi Asmundo, Aileen O'Shea, Bashar Kako, Susanna Lee, Felipe S Furtado, Michael Blake, Reece J Goiffon, Zahra Najmi, Mina Hesami, Takaaki Murakami, Liran Domachevsky, Onofrio A Catalano
Neuroendocrine neoplasms (NENs) may be challenging to diagnose due to their small size and diverse anatomical locations. Hybrid imaging techniques, specifically positron emission tomography/computed tomography (PET/CT) and positron emission tomography/magnetic resonance imaging (PET/MRI), represent the current state-of-the-art for evaluating NENs. The preferred radiopharmaceuticals for NEN PET imaging are gallium-68 (68Ga) DOTA-peptides, which target somatostatin receptors (SSTR) overexpressed on NEN cells...
March 25, 2024: Journal of Computer Assisted Tomography